EGFR-IN-7 3-C2-NH-Boc Smiles: CC1=CC(=C(C=C1C)C1=CC=C(/C=C2\C(=O)N(N=C\2C)C2C=CC(=CC=2)C(O)=O)O1)[N+]([O-])=O

Smiles: CC1=CC(=C(C=C1C)C1=CC=C(/C=C2\C(=O)N(N=C\2C)C2C=CC(=CC=2)C(O)=O)O1)[N+]([O-])=O

therefore KDM5-C70 was developed as a pro-drug

4-dihydroxyphenyl)-2-hydroxypropanoate

increased caspase-3 and appearance of increased nuclear size

7aH-cyclopenta[c]pyran-4-carboxylic acid

EGFR-IN-7 3-C2-NH-Boc Smiles: CC1=CC(=C(C=C1C)C1=CC=C(/C=C2\C(=O)N(N=C\2C)C2C=CC(=CC=2)C(O)=O)O1)[N+]([O-])=OEGFR IN 7 (compound 34) is a selective and potent EGFR kinase inhibitor extracted from patent WO2019015655A1, has IC50s of 7. 92 nM and 0. 218 nM for EGFR (WT) and EGFR (mutant C797S T790M L858R) respectively, and shows anti tumor activity. Product information CAS Number: 2267329 76 8 Molecular Weight: 694. 60 Formula: C32H41BrN9O2P Chemical Name: 5 bromo N4 [5 (dimethylphosphoryl)quinoxalin 6 yl] N2 {2 methoxy 5 methyl 4 [4 (4 methylpiperazin 1